Carbimazole
As of the edition of 20 October 2026, Carbimazole is a small molecule: marketed, first approved in 1955 (CH); acts on TPO.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1988
- Kind
- Small molecule
- Brand name
- Néo-Mercazole
- First approved
- 13 January 1955 (CH)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Amdipharm; 3 holders in all
- Registered trials
- 1, 0 stopped early
- Disease areas
- Hormones
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| TPO | Thyroid peroxidase | P07202 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| All trials | 1 |